Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib Trial Evaluating the Combination of CDK4 Inhibitor With Immunotherapy in Patients With Sarcoma

NCT06113809 is registered in ClinicalTrials.gov with John Rieth as lead sponsor.

NCT NCT06113809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06113809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib Trial Evaluating the Combination of CDK4 Inhibitor With Immunotherapy in Patients With Sarcoma
Lead sponsor
John Rieth
Phase
Phase 1
Overall status
Recruiting
Start date
February 1, 2024
Completion date
July 31, 2028
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma